Home » In Vitro Colorectal Cancer Screening Market

Global In-Vitro Colorectal Cancer Screening Market By Product (Fecal Occult Blood Tests, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test, Biomarker Tests, Tumor M2-PK Stool Test, Transferrin Assays, CRC DNA Screening Tests, Methylated Gene Testing, and Panel DNA Tests) By Imaging Type (Colonoscopy, Proctoscopy, CT Scan, Ultrasound, MRI, and PET Scan)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 6205 | Report Format : PDF

Key Highlights of the report

How are the major segments performing in the in-vitro colorectal cancer screening market?

  • In 2021, the fecal occult blood tests segment accounted for the largest share of the market as they are commonly used for cancer screening.
  • In 2021, the colonoscopy segment was anticipated to hold a prominent share in the global in-vitro colorectal cancer screening market as it provides accurate results coupled with increasing incidences of colorectal cancer.
  • In 2021, the hospital’s segment held the largest market share of the in-vitro colorectal cancer screening market, owing to increasing patient visits for cancer diagnosis in hospitals.

What is the market size of in-vitro colorectal cancer screening regarding value?

The global in-vitro colorectal cancer screening market is anticipated to grow at a substantial CAGR of 5.80% in the upcoming years. The global in-vitro colorectal cancer screening industry was estimated to be worth USD 842.5 million in 2021 and was expected to be worth USD 1181.64 million by 2028.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Which region dominated the in-vitro colorectal cancer screening market?

In 2021, the North American region held the largest share of the global in-vitro colorectal cancer screening market. The increasing prevalence of colorectal cancer has led to the growing need for screening tests that can help diagnose it. Moreover, technological advancement and growing awareness of cancer testing are some of the major drivers of market growth in this region.

How is US Market Performing in the In-Vitro Colorectal Cancer Screening market?

The U.S. held the larger of the North American region in 2021. Factors include higher incidences of colorectal cancer, a rising geriatric population, and growing tests for cancer diagnosis. For instance, according to the Centers for Disease Control and Prevention, in 2020, around 64 million people aged 50 to 75 were screened for colorectal cancer in the U.S. Out of these, 19.9% of adults were who were never screened for colorectal cancer before 2020. Most of this population used FIT, colonoscopy, sigmoidoscopy, FIT-DNA, and CT colonography to screen colorectal cancer.

What is the competitive environment of the in-vitro colorectal cancer screening market?

Companies in the in-vitro colorectal cancer market are strongly increasing their focus on expansion by launching new advanced products for screening colorectal cancer. For instance, in Oct 2021, FUJIFILM launched its new product EI-740D/S dual-channel endoscope. The product was also cleared by the U.S. FDA (Food and Drug Administration) for its use in the lower as well as upper gastrointestinal. Similarly, in May 2022, Guardant launched the Shield test, a lab-developed test for the detection of colorectal cancer among average-risk adults. Moreover, companies are also investing in R&D to develop new products to screen colorectal cancer.

Executive Summary

What are the key trends in the In-Vitro Colorectal Cancer Screening market?

  • Technological advancements in the instruments used for screening of colorectal cancer.
  • Growing government support for creating awareness regarding cancer screening is one of the key factors anticipated to boost the number of screening tests for colorectal cancer globally.

How is the Growing Prevalence of Cancer Affecting the In-Vitro Colorectal Cancer Screening Market?

Colorectal cancer is one most commonly caused cancer. It is the third leading cause of cancer-related deaths in men as well as women in the U.S. According to the statistics published by the American Cancer Society, the overall risk of developing colorectal cancer is 1 in 25 in women and 1 in 23 in men. According to the National Cancer Institute, estimated new cases of colorectal cancer in 2022 are around 151,030, and an estimated death of 52,580. Owing to such an increasing prevalence of colorectal cancer, the need for diagnosis among the population is rising globally. Thus, cancer’s growing prevalence is one of the key drivers of in-vitro colorectal cancer screening.

REPORT ATTRIBUTE DETAILS
In-Vitro Colorectal Cancer Screening Market by Volume Yes
In-Vitro Colorectal Cancer Screening Market by Value Yes
In-Vitro Colorectal Cancer Screening Market, Tornado Analysis Yes
In-Vitro Colorectal Cancer Screening Market, STAR Analysis Yes
In-Vitro Colorectal Cancer Screening Market, SRC Analysis Yes
In-Vitro Colorectal Cancer Screening Market Pricing Analysis Yes (On Demand)
In-Vitro Colorectal Cancer Screening Market Segment Analysis By Product (Fecal Occult Blood Tests, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test, Biomarker Tests, Tumor M2-PK Stool Test, Transferrin Assays, CRC DNA Screening Tests, Methylated Gene Testing, and Panel DNA Tests)

By Imaging Type (Colonoscopy, Proctoscopy, CT Scan, Ultrasound, MRI, and PET Scan)

By End User (Hospitals, Clinics, Diagnostics Laboratories, and Others)

 

In-Vitro Colorectal Cancer Screening Market, Regional Analysis North America (US and Canada)

Europe (Germany, UK, France, Italy, Spain, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)

In-Vitro Colorectal Cancer Screening Market Key Companies Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.
In-Vitro Colorectal Cancer Screening Market Competitive Landscape Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

Which are the key investments by the In-Vitro Colorectal Cancer Screening market players?

Prominent players operating in the market are focusing on growing R&D activities for developing products for the screening of colorectal cancer. Companies are also raising funds and investments to expand their R&D activities, such as successfully launching new products in the market that help them strengthen their position in the market. For instance, in Jan 2022, Roche invested USD 300 million in Freenome, a Bay Area-based company. The investment is anticipated to support the company’s colorectal cancer development. Freenome is developing a machine learning-based multi-omics blood test that helps in the early detection of colorectal cancer. Similarly, in December 2021, the Colorectal Cancer Alliance (Alliance), a non-profit organization committed to ending colorectal cancer, invested USD 30 million for research for the next five years (up to 2024).

Some major players in the in-vitro colorectal cancer screening market are Beckman Coulter Inc. (Danaher Corporation), Eiken Chemical Co. Ltd., Epigenomics AG, Exact Sciences Corporation, Hemosure Inc., Immunostics Inc. (Boditech Med Inc.), Medline Industries LP, Merck KGaA, Qiagen N.V., Quest Diagnostics Incorporated, R-Biopharm AG, Siemens AG and Sysmex Corporation.

What are the Major Driving Factors for the In-Vitro Colorectal Cancer Screening Market?

The rising incidence of colorectal cancer among men and women, the growing need for tests that help diagnose colorectal cancer as undiagnosed cancer can lead to death, and increasing awareness for the detection of cancer are among the major factors propelling the in-vitro colorectal cancer screening market growth. Moreover, growing R&D activities for expanding their product portfolio coupled with rising private as well as government investment to drive the market growth during the forecast period. Furthermore, increasing advancements in the testing methods, such as genetic tests that provide increased accuracy, are also fuelling the use of these tests.

In-Vitro Colorectal Cancer Screening Market

What are the Major Risks for the in-vitro colorectal cancer screening Market?

Adverse effects of colonoscopy tests, such as bleeding infection, are some factors limiting the use of these tests. Moreover, complications post colonoscopy, such as belly cramps, severe pain, trouble in passing stool, dizziness, fever nausea, are expected to reduce the number of tests performed. Moreover, in rural areas, the awareness of testing is low. Such factors are anticipated to hinder market growth to a certain extent.

Which is the key imaging type used in in-vitro colorectal cancer screening?

The colonoscopy segment is expected to hold a major share of the global in-vitro colorectal cancer screening market during the forecast period. Colonoscopy is one of the major imaging tests used to diagnose colorectal cancer. Companies in the market are also launching various colonoscopy tests. For instance, in March 2021, Olympus Corporation received approval from Narrow Band Imaging (NBI) for accessing the potential of colorectal polyps. With the application of NBI International Colorectal Endoscopy (NICE) during the screening process, physicians can easily predict the histology of smaller polyps. Such factors are boosting the use of these tests for the screening process and driving segmental growth.

How is the in-vitro colorectal cancer screening market performing in regions?

Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. The rising geriatric population, coupled with the increasing incidence of colorectal cancer among men and women, is expected to boost market growth during the forecast period. Moreover, the mortality rate of cancer, especially colorectal cancer, is high in this region. This has led the government to take several initiatives to increase awareness of screening tests for detecting cancer. Growing awareness is expected to rise the demand for diagnostic tests and, in turn, propel market growth in this region.

What is the regulatory landscape for the in-vitro colorectal cancer screening market?

The approval process for launching a new screening test or product used for screening is very long. Several years of R&D and studies are required to prove that the test is not harmful to humans and is efficient in receiving approval. Several regulatory bodies approve these products, and only companies can launch the products in the market. The U.S. Food and Drugs Association, The European Medicines Agency (EMA), National Medical Products Administration (NMPA), and Health Canada are some regulatory bodies that access the applications for approval of a new screening test or product. Companies must present a detailed application to these organizations with all the specifications, and if they pass all the criteria, they receive approval.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the in-vitro colorectal cancer screening market?

Companies are strongly conducting R&D activities for studying and developing new products. For instance, in May 2018, CellMax Life launched a clinical study designed to accessing the effectiveness of CTC blood tests for detecting colorectal cancer. The company planned to conduct these studies in top U.S medical centers that include the U.S. Department of Veterans Affairs Palo Alto Health Care System, Stanford Medicine, University of Southern California, and Johns Hopkins. Similarly, in January 2021, a privately held company SOLVD Health launched a clinical study on LifeKit Prevent, non-invasive colorectal cancer (CRC) screening test. The test is designed in such a way that it can detect and analyze the microbial genomics biomarkers present in stool samples that are associated with CRC progression.

Segmentation of Global In-Vitro Colorectal Cancer Screening Market-

Global In-Vitro Colorectal Cancer Screening Market – By Products

  • Fecal Occult Blood Tests
  • Guaiac FOB Stool Test
  • Immuno-FOB Agglutination Test
  • Lateral Flow Immuno-FOB Test
  • Immuno-FOB ELISA Test
  • Biomarker Tests
  • Tumor M2-PK Stool Test
  • Transferrin Assays
  • CRC DNA Screening Tests
  • Methylated Gene Testing
  • Panel DNA Tests

Global In-Vitro Colorectal Cancer Screening Market – By Imaging Type

  • Colonoscopy
  • Proctoscopy
  • CT Scan
  • Ultrasound
  • MRI
  • PET Scan

Global In-Vitro Colorectal Cancer Screening Market – By End User

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

Global In-Vitro Colorectal Cancer Screening Market – By Region

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global In-Vitro Colorectal Cancer Screening Market
2.2. Global In-Vitro Colorectal Cancer Screening Market, By Product
2.3. Global In-Vitro Colorectal Cancer Screening Market, By Imaging Type
2.4. Global In-Vitro Colorectal Cancer Screening Market, By End User
2.5. Global In-Vitro Colorectal Cancer Screening Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global In-Vitro Colorectal Cancer Screening Market Value, 2016-2028, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product
3.5.2. Imaging Type
3.5.3. Deployment
3.5.4. Platform
3.5.5. End User
3.5.6. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID-19 Impact Analysis
6.1. Global In-Vitro Colorectal Cancer Screening Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global In-Vitro Colorectal Cancer Screening Market
7.1. Global In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global In-Vitro Colorectal Cancer Screening Market, By Product, 2021 vs 2028 (in%)
7.1.3. Global In-Vitro Colorectal Cancer Screening Market, By Fecal Occult Blood Tests, 2016-2028 (US$ Bn)
7.1.4. Global In-Vitro Colorectal Cancer Screening Market, By Guaiac FOB Stool Test, 2016-2028 (US$ Bn)
7.1.5. Global In-Vitro Colorectal Cancer Screening Market, By Immuno-FOB Agglutination Test, 2016-2028 (US$ Bn)
7.1.6. Global In-Vitro Colorectal Cancer Screening Market, By Lateral Flow Immuno-FOB Test, 2016-2028 (US$ Bn)
7.1.7. Global In-Vitro Colorectal Cancer Screening Market, By Immuno-FOB ELISA Test, 2016-2028 (US$ Bn)
7.1.8. Global In-Vitro Colorectal Cancer Screening Market, By Biomarker Tests, 2016-2028 (US$ Bn)
7.1.9. Global In-Vitro Colorectal Cancer Screening Market, By Tumor M2-PK Stool Test, 2016-2028 (US$ Bn)
7.1.10. Global In-Vitro Colorectal Cancer Screening Market, By Transferrin Assays, 2016-2028 (US$ Bn)
7.1.11. Global In-Vitro Colorectal Cancer Screening Market, CRC DNA Screening Tests, 2016-2028 (US$ Bn)
7.1.12. Global In-Vitro Colorectal Cancer Screening Market, By Methylated Gene Testing, 2016-2028 (US$ Bn)
7.1.13. Global In-Vitro Colorectal Cancer Screening Market, By Panel DNA Tests, 2016-2028 (US$ Bn)
7.2. Global In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global In-Vitro Colorectal Cancer Screening Market, By Imaging Type, 2021 vs 2028 (in%)
7.2.3. Global In-Vitro Colorectal Cancer Screening Market, By Colonoscopy, 2016-2028 (US$ Bn)
7.2.4. Global In-Vitro Colorectal Cancer Screening Market, By Proctoscopy, 2016-2028 (US$ Bn)
7.2.5. Global In-Vitro Colorectal Cancer Screening Market, By CT Scan, 2016-2028 (US$ Bn)
7.2.6. Global In-Vitro Colorectal Cancer Screening Market, By Ultrasound, 2016-2028 (US$ Bn)
7.2.7. Global In-Vitro Colorectal Cancer Screening Market, By MRI, 2016-2028 (US$ Bn)
7.2.8. Global In-Vitro Colorectal Cancer Screening Market, By PET Scan, 2016-2028 (US$ Bn)
7.3. Global In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global In-Vitro Colorectal Cancer Screening Market, By End User, 2021 vs 2028 (in%)
7.3.3. Global In-Vitro Colorectal Cancer Screening Market, By Hospitals, 2016-2028 (US$ Bn)
7.3.4. Global In-Vitro Colorectal Cancer Screening Market, By Clinics, 2016-2028 (US$ Bn)
7.3.5. Global In-Vitro Colorectal Cancer Screening Market, By Diagnostic Laboratories, 2016-2028 (US$ Bn)
7.3.6. Global In-Vitro Colorectal Cancer Screening Market, By Others, 2016-2028 (US$ Bn)

8. North America In-Vitro Colorectal Cancer Screening Market Analysis
8.1. North America In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. U.S. In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
8.4.1.3. U.S. In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
8.4.1.4. U.S. In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. Canada In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
8.4.2.3. Canada In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
8.4.2.4. Canada In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)

9. Europe In-Vitro Colorectal Cancer Screening Market Analysis
9.1. Europe In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. Germany In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
9.4.1.3. Germany In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
9.4.1.4. Germany In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
9.4.2. France
9.4.2.1. France In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. France In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
9.4.2.3. France In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
9.4.2.4. France In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
9.4.3. UK
9.4.3.1. UK In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. UK In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
9.4.3.3. UK In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
9.4.3.4. UK In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. Italy In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
9.4.4.3. Italy In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
9.4.4.4. Italy In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. Spain In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
9.4.5.3. Spain In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
9.4.5.4. Spain In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Europe In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Europe In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
9.4.6.4. Rest of Europe In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)

10. Asia Pacific In-Vitro Colorectal Cancer Screening Market Analysis
10.1. Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
10.4.1. China
10.4.1.1. China In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.1.2. China In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
10.4.1.3. China In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
10.4.1.4. China In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.2.2. Japan In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
10.4.2.3. Japan In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
10.4.2.4. Japan In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
10.4.3. India
10.4.3.1. India In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.3.2. India In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
10.4.3.3. India In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
10.4.3.4. India In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.4.2. South Korea In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
10.4.4.3. South Korea In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
10.4.4.4. South Korea In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.5.2. South-East Asia In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
10.4.5.3. South-East Asia In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
10.4.5.4. South-East Asia In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.6.2. Rest of Asia Pacific In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
10.4.6.3. Rest of Asia Pacific In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
10.4.6.4. Rest of Asia Pacific In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)

 

11. Latin America In-Vitro Colorectal Cancer Screening Market Analysis
11.1. Latin America In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.1.2. Brazil In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
11.4.1.3. Brazil In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
11.4.1.4. Brazil In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.2.2. Mexico In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
11.4.2.3. Mexico In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
11.4.2.4. Mexico In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.3.2. Rest of Latin America In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
11.4.3.3. Rest of Latin America In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
11.4.3.4. Rest of Latin America In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)

12. Middle East and Africa In-Vitro Colorectal Cancer Screening Market Analysis
12.1. Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries il In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.1.2. GCC Countries In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
12.4.1.3. GCC Countries In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
12.4.1.4. GCC Countries In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.2.2. South Africa In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
12.4.2.3. South Africa In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
12.4.2.4. South Africa In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening, By Product, 2016-2028 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening, By Imaging Type, 2016-2028 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening, By End User, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. Beckman Coulter Inc. (Danaher Corporation)
13.1.1. Company Overview
13.1.2. Products/Immuno-FOB Agglutination Test Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Eiken Chemical Co. Ltd.
13.3. Epigenomics AG
13.4. Exact Sciences Corporation
13.5. Hemosure Inc.
13.6. Immunostics Inc. (Boditech Med Inc.)
13.7. Medline Industries LP
13.8. Merck KGaA
13.9. Qiagen N.V.
13.10. Quest Diagnostics Incorporated
13.11. R-Biopharm AG
13.12. Siemens AG
13.13. Sysmex Corporation.
13.14. Others

List of Figures
FIG. 1 Global In-Vitro Colorectal Cancer Screening Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global In-Vitro Colorectal Cancer Screening Market Segmentation
FIG. 4 Global In-Vitro Colorectal Cancer Screening Market, by Product, 2021 (US$ Bn)
FIG. 5 Global In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2021 (US$ Bn)
FIG. 6 Global In-Vitro Colorectal Cancer Screening Market, by End User, 2021 (US$ Bn)
FIG. 7 Global In-Vitro Colorectal Cancer Screening Market, by Geography, 2021 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Product, 2021
FIG. 9 Attractive Investment Proposition, by Imaging Type, 2021
FIG. 10 Attractive Investment Proposition, by End User, 2021
FIG. 11 Attractive Investment Proposition, by Geography, 2021
FIG. 12 Global Market Share Analysis of Key In-Vitro Colorectal Cancer Screening Market Manufacturers, 2021
FIG. 13 Global Market Positioning of Key In-Vitro Colorectal Cancer Screening Market Manufacturers, 2021
FIG. 14 Global In-Vitro Colorectal Cancer Screening Market Value Contribution, By Product, 2021 & 2028 (Value %)
FIG. 15 Global In-Vitro Colorectal Cancer Screening Market, by Fecal Occult Blood Tests, Value, 2016-2028 (US$ Bn)
FIG. 16 Global In-Vitro Colorectal Cancer Screening Market, by Guaiac FOB Stool Test, Value, 2016-2028 (US$ Bn)
FIG. 17 Global In-Vitro Colorectal Cancer Screening Market, by Immuno-FOB Agglutination Test, Value, 2016-2028 (US$ Bn)
FIG. 18 Global In-Vitro Colorectal Cancer Screening Market, by Lateral Flow Immuno-FOB Test, Value, 2016-2028 (US$ Bn)
FIG. 19 Global In-Vitro Colorectal Cancer Screening Market, by Immuno-FOB ELISA Test, Value, 2016-2028 (US$ Bn)
FIG. 20 Global In-Vitro Colorectal Cancer Screening Market, by Biomarker Tests, Value, 2016-2028 (US$ Bn)
FIG. 21 Global In-Vitro Colorectal Cancer Screening Market, by Tumor M2-PK Stool Test, Value, 2016-2028 (US$ Bn)
FIG. 22 Global In-Vitro Colorectal Cancer Screening Market, by Transferrin Assays, Value, 2016-2028 (US$ Bn)
FIG. 23 Global In-Vitro Colorectal Cancer Screening Market, by CRC DNA Screening Tests, Value, 2016-2028 (US$ Bn)
FIG. 24 Global In-Vitro Colorectal Cancer Screening Market, by Methylated Gene Testing, Value, 2016-2028 (US$ Bn)
FIG. 25 Global In-Vitro Colorectal Cancer Screening Market, by Panel DNA Tests, Value, 2016-2028 (US$ Bn)
FIG. 26 Global In-Vitro Colorectal Cancer Screening Market Value Contribution, By Imaging Type, 2021 & 2028 (Value %)
FIG. 27 Global In-Vitro Colorectal Cancer Screening Market, by Colonoscopy, Value, 2016-2028 (US$ Bn)
FIG. 28 Global In-Vitro Colorectal Cancer Screening Market, by Proctoscopy, Value, 2016-2028 (US$ Bn)
FIG. 29 Global In-Vitro Colorectal Cancer Screening Market, by CT Scan, Value, 2016-2028 (US$ Bn)
FIG. 30 Global In-Vitro Colorectal Cancer Screening Market, by Ultrasound, Value, 2016-2028 (US$ Bn)
FIG. 31 Global In-Vitro Colorectal Cancer Screening Market, by MRI, Value, 2016-2028 (US$ Bn)
FIG. 32 Global In-Vitro Colorectal Cancer Screening Market, by PET Scan, Value, 2016-2028 (US$ Bn)
FIG. 33 Global In-Vitro Colorectal Cancer Screening Market Value Contribution, By End User, 2021 & 2028 (Value %)
FIG. 34 Global In-Vitro Colorectal Cancer Screening Market, by Hospitals, Value, 2016-2028 (US$ Bn)
FIG. 35 Global In-Vitro Colorectal Cancer Screening Market, by Clinics, Value, 2016-2028 (US$ Bn)
FIG. 36 Global In-Vitro Colorectal Cancer Screening Market, by Diagnostic Laboratories, Value, 2016-2028 (US$ Bn)
FIG. 37 Global In-Vitro Colorectal Cancer Screening Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 38 U.S. In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 39 Canada In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 40 Germany In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 41 France In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 42 U.K. In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 43 Italy In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 44 Spain In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 45 Rest of Europe In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 46 China In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 47 Japan In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 48 India In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 49 South Korea In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 50 Southeast Asia In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 51 Rest of Asia Pacific In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 52 Latin America In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 53 Brazil In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 54 Mexico In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 55 Rest of Latin America In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 56 Middle East & Africa In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 57 GCC Countries In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 58 South Africa In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)
FIG. 59 Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Market, 2016-2028 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global In-Vitro Colorectal Cancer Screening Market
TABLE 2 Global In-Vitro Colorectal Cancer Screening Market, by Competitive Benchmarking, 2021
TABLE 3 Global In-Vitro Colorectal Cancer Screening Market, by Geographical Presence Analysis, 2021
TABLE 4 Global In-Vitro Colorectal Cancer Screening Market, by Key Strategies Analysis, 2021
TABLE 5 Global In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 6 Global In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 7 Global In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 8 Global In-Vitro Colorectal Cancer Screening Market, by Geography, 2016-2028 (US$ Bn)
TABLE 9 North America In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 10 North America In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 11 North America In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 12 North America In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
TABLE 13 US In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 14 US In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 15 US In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 16 Canada In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 17 Canada In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 18 Canada In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 19 Europe In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 20 Europe In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 21 Europe In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 22 Europe In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
TABLE 23 Germany In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 24 Germany In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 25 Germany In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 26 France In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 27 France In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 28 France In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 29 UK In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 30 UK In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 31 UK In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 32 Italy In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 33 Italy In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 34 Italy In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 35 Spain In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 36 Spain In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 37 Spain In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 38 Rest of Europe In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 39 Rest of Europe In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 40 Rest of Europe In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 41 Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 42 Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 43 Asia Pacific In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 44 Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
TABLE 45 China In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 46 China In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 47 China In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 48 Japan In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 49 Japan In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 50 Japan In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 51 India In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 52 India In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 53 India In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 54 South Korea In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 55 South Korea In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 56 South Korea In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 57 South East Asia In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 58 South East Asia In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 59 South East Asia In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 60 Rest of Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 61 Rest of Asia Pacific In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 62 Rest of Asia Pacific In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 63 Latin America In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 64 Latin America In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 65 Latin America In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 66 Latin America In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
TABLE 67 Brazil In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 68 Brazil In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 69 Brazil In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 70 Mexico In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 71 Mexico In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 72 Mexico In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 73 Rest of Latin America In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 74 Rest of Latin America In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 75 Rest of Latin America In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 76 Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 77 Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 78 Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 79 Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Country, 2016-2028 (US$ Bn)
TABLE 80 GCC Countries In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 81 GCC Countries In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 82 GCC Countries In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 83 South Africa In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 84 South Africa In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 85 South Africa In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)
TABLE 86 Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Product, 2016-2028 (US$ Bn)
TABLE 87 Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by Imaging Type, 2016-2028 (US$ Bn)
TABLE 88 Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Market, by End User, 2016-2028 (US$ Bn)

Frequently Asked Questions

How does COVID-19 Impact the global In- in-vitro colorectal cancer screening market?

COVID-19 pandemic had a substantial impact on the healthcare sector. The in-vitro colorectal cancer screening market was also affected owing to the pandemic. Restrictions imposed by the government, a lower number of patients visiting hospitals & clinics, and an increasing focus on doctors for screening COVID-19 patients were some factors affecting the market

Which is the leading region of the market for in-vitro colorectal cancer screening?

North America accounted for the largest share of the global In-vitro colorectal cancer screening market.


What are the key drivers for the growth of the in-vitro colorectal cancer screening market?

The growing prevalence of colorectal cancer and the rising need for testing for cancer diagnosis are the key drivers of the in-vitro colorectal cancer screening market growth.

Which is the major segment in the in-vitro colorectal cancer screening market by product?

The fecal occult blood tests segment had a major share in the global market in 2021.

Which is the major segment in the in-vitro colorectal cancer screening market by Imaging Type?

The colonoscopy segment had a major share in the global market.

Nontuberculous Mycobacterial (NTM) Infection Market

Published:
Report ID: 33051

Plant Stem Cell Market

Published:
Report ID: 9766

Pharmaceutical Rapid Microbiology Testing Market

Published:
Report ID: 9476

Plant Stem Cell Nutrition Products Market

Published:
Report ID: 9775

Biological Data Visualization Market

Published:
Report ID: 32405

Bioprocess Validation Market

Published:
Report ID: 31245

Baculovirus Expression System Market

Published:
Report ID: 31033

Red Biotechnology Market

Published:
Report ID: 30876

Enzymatic DNA Synthesis Market

Published:
Report ID: 23339

Oligonucleotide API Market

Published:
Report ID: 23006

Next Generation Sequencing Market

Published:
Report ID: 14469

Small Molecule Drug Discovery Market

Published:
Report ID: 22652

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN